JAPAY:OTC-Japan Tobacco ADR (USD)

COMMON STOCK | Tobacco |

Last Closing

USD 14.49

Change

0.00 (0.00)%

Market Cap

USD 52.78B

Volume

0.03M

Analyst Target

USD 8.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Tobacco

Symbol Name Price(Change) Market Cap
BTAFF British American Tobacco p.l.c

N/A

USD 81.26B
IMBBY Imperial Brands PLC

N/A

USD 24.96B
IMBBF Imperial Brands PLC

N/A

USD 24.50B
SMORF Smoore International Holdings ..

N/A

USD 8.20B
PHJMF PT Hanjaya Mandala Sampoerna T..

N/A

USD 5.74B
GGNPF PT Gudang Garam Tbk

N/A

USD 2.19B
STBGY Scandinavian Tobacco Group A/S

-0.10 (-1.28%)

USD 1.25B
SNDVF Scandinavian Tobacco Group A/S

N/A

USD 1.25B
GLBGF Globrands Ltd

N/A

USD 0.18B
PYYX Pyxus International Inc

N/A

USD 0.06B

ETFs Containing JAPAY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Tobacco) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.59% 71% C- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.59% 64% D 63% D
Trailing 12 Months  
Capital Gain 30.66% 76% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.66% 64% D 72% C
Trailing 5 Years  
Capital Gain 31.01% 58% F 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.01% 42% F 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 8.51% N/A N/A 52% F
Dividend Return 8.51% N/A N/A 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.72% N/A N/A 90% A-
Risk Adjusted Return 50.88% N/A N/A 86% B+
Market Capitalization 52.78B 95% A 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.